| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: Design of the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T (RAPID-TnT) study
|
Papendick, Cynthia
|
|
2017
|
190 |
C |
p. 25-33
9 p.
|
article
|
| 2 |
Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort
|
Jiang, Rong
|
|
2017
|
190 |
C |
p. 40-45
6 p.
|
article
|
| 3 |
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients
|
Palmerini, Tullio
|
|
2017
|
190 |
C |
p. 54-63
10 p.
|
article
|
| 4 |
County socioeconomic characteristics and heart transplant outcomes in the United States
|
Tumin, Dmitry
|
|
2017
|
190 |
C |
p. 104-112
9 p.
|
article
|
| 5 |
Editorial Board
|
|
|
2017
|
190 |
C |
p. v-
1 p.
|
article
|
| 6 |
Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial
|
Gimpelewicz, Claudio
|
|
2017
|
190 |
C |
p. 113-122
10 p.
|
article
|
| 7 |
Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
|
Hijazi, Ziad
|
|
2017
|
190 |
C |
p. 94-103
10 p.
|
article
|
| 8 |
High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease
|
Sara, Jaskanwal D.S.
|
|
2017
|
190 |
C |
p. 1-11
11 p.
|
article
|
| 9 |
Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction: Design and rationale of the SMART-MI trial
|
Hamm, Wolfgang
|
|
2017
|
190 |
C |
p. 34-39
6 p.
|
article
|
| 10 |
Information for Readers
|
|
|
2017
|
190 |
C |
p. vi-
1 p.
|
article
|
| 11 |
Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocol
|
Ivers, Noah
|
|
2017
|
190 |
C |
p. 64-75
12 p.
|
article
|
| 12 |
Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium
|
Idriss, Salim F.
|
|
2017
|
190 |
C |
p. 123-131
9 p.
|
article
|
| 13 |
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
|
Kirchhof, Paulus
|
|
2017
|
190 |
C |
p. 12-18
7 p.
|
article
|
| 14 |
Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant
|
Austin, Christopher O.
|
|
2017
|
190 |
C |
p. 46-53
8 p.
|
article
|
| 15 |
Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE-AF) randomized trial: Design and rationale
|
Bernstein, Richard A.
|
|
2017
|
190 |
C |
p. 19-24
6 p.
|
article
|
| 16 |
Table of Contents
|
|
|
2017
|
190 |
C |
p. i-iii
nvt p.
|
article
|
| 17 |
The troponin decision-point dilemma: The 99th percentile solution “do the best you can [with cardiac troponin] until you know better. Then when you know better, do better.” Maya Angelou, poet, dancer, producer, playwright, director, author
|
Christenson, Robert H.
|
|
2017
|
190 |
C |
p. 132-134
3 p.
|
article
|
| 18 |
Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry
|
Proietti, Marco
|
|
2017
|
190 |
C |
p. 86-93
8 p.
|
article
|
| 19 |
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium
|
Seltzer, Jonathan H.
|
|
2017
|
190 |
C |
p. 76-85
10 p.
|
article
|
| 20 |
Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis
|
Bagai, Akshay
|
|
2017
|
190 |
C |
p. 135-139
5 p.
|
article
|
Journal description